← Back

Double Medical Technology Inc

Double Medical Technology Inc. researches, develops, produces, and sells high-value medical consumables in China. Its products include orthopedic trauma, spinal, joint, sports medicine, neurosurgery, minimally invasive surgical, and dental implants. The company also exports its products. Formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited, it was incorporated in 2004 and is headquartered in Xiamen, China.

Country
Price · split & dividend adjusted
News & notes moving 002901.CS
002901.CS

Zhongji Innolight repurchases over 300 million yuan on first day; multiple A-share companies disclose buyback progress

Several A-share companies disclosed progress on share buybacks. Among them, Zhongji Innolight repurchased 374,100 shares on the first day after announcing a planned buyback of up to 8 billion yuan, paying a total of 318 million yuan. As of August 31, China Petroleum and Chemical Corporation had cumulatively repurchased 104 million A-shares for a total of 500 million yuan; Jiuzhou Pharmaceutical had repurchased 15.41 million shares for 212 million yuan; MGI Tech had repurchased 2.01 million shares for about 100 million yuan; Double Medical Technology had repurchased 6.21 million shares for 260 million yuan; Jiansheng Group had repurchased 19.25 million shares for 224 million yuan; and Bear Electric Appliance had repurchased 1.95 million shares for 65.95 million yuan.
证券时报·18dRead more →
002901.CS3

Double Medical Technology's 2026 interim net profit reaches 353 million yuan

Double Medical Technology released its 2026 interim report, with total operating revenue of 1.34 billion yuan, net profit attributable to the parent company of 353 million yuan, and net operating cash inflow of 276 million yuan. The company's latest asset-liability ratio is 29.92 percent, up 6.56 percentage points from the previous quarter and up 4.01 percentage points from the same period last year. Gross margin is 74.45 percent, return on equity is 10.05 percent, and diluted earnings per share is 0.86 yuan. Total asset turnover is 0.27 times, down 3.30 percent year on year, and inventory turnover is 0.27 times, down 2.14 percent year on year. The number of shareholders is 19,400, and the top ten shareholders hold 86.76 percent of the total share capital.
Jiemian·23dRead more →
002901.CS

Double Medical Technology Appoints Controlling Shareholder Lin Zhixiong as General Manager

Double Medical Technology Incorporated announced the appointment of Lin Zhixiong, the company's actual controller, as general manager, with a term lasting until the end of the fourth board of directors. Lin Zhixiong directly holds 86,203,902 shares of the company and indirectly controls 97,124,098 shares through Guangxi Double Medical Shangtong Venture Capital Company Limited, together controlling 44.28% of the company's total share capital. The company stated that this move will help coordinate business decisions, improve management efficiency, and ensure strategic stability and continuity. Lin Zhixiong meets the qualifications for the position and there are no circumstances that would prevent him from serving as a senior manager of a listed company.
Jiemian·24dRead more →
002901.CS

Double Medical to Distribute 6 Yuan per 10 Shares, Record Date July 6

Double Medical will set July 6, 2026 as the record date, with ex-dividend and ex-rights on July 7. The company will distribute a cash dividend of 6.00 yuan per 10 shares, tax inclusive. It is a constituent of the Dividend Quality Index, which selects 50 listed companies with consistent cash dividends, high payout ratios, and strong profitability. As of July 3, the index had a trailing 12-month dividend yield of 3.17 percent. As of 1:44 p.m. on July 6, the Dividend Quality Index was up 0.33 percent, while the only ETF tracking it, the ChinaAMC Dividend Quality ETF, rose 0.36 percent.
每日经济新闻·75dRead more →